Risk assessment of infected children with Pseudomonas aeruginosa pneumonia by combining host and pathogen predictors
- PMID: 29146549
- DOI: 10.1016/j.meegid.2017.11.015
Risk assessment of infected children with Pseudomonas aeruginosa pneumonia by combining host and pathogen predictors
Abstract
The current criteria of pneumonia severity, which mainly depend on clinical manifestations and laboratory findings from blood routine tests and X-ray examination, are still of great significance in preliminary diagnosis. However, the utility of traditional severe pneumonia indexes (SPI) without considering high virulence and multidrug resistance of Pseudomonas aeruginosa has limitations. Thus, it is of great value to make a risk assessment, which can serve as a complementary option for incomplete clinical diagnosis. This study aims to determine risk factors related to severe pneumonia and to comprehensively evaluate the risk conditions of infected children with P. aeruginosa pneumonia. We collected the clinical information of 184 hospitalized children with P. aeruginosa pneumonia and measured pathogen data on virulence factors and drug resistance. The risk assessment matrix was formed from the significant host and pathogen predictors, and the risk score was determined by the clinical references and the optimal critical values (OCV) of the receiver operator characteristic (ROC) curves. There were 103 (56%) and 81 (44%) infected children diagnosed as mild and severe pneumonia by SPI, respectively. Seven risk factors were significantly associated with severe pneumonia, including body temperature, respiratory rate, C-reactive protein, elastase, exotoxin-A, exoenzyme-U and multidrug resistances. Among 184 infected children, the risk assessment matrix displayed 62 cases (34%) at high risk, 51 cases (28%) at medium risk, and 71 cases (38%) at low risk in terms of pneumonia severity. On the basis of the SPI preliminary diagnosis, the risk assessment prompted that 31% (32/103) mild patients would be faced with a poorer outcome and 23% (19/81) severe patients might get a better prognosis. Therefore, the well-established assessment indicates that the interplay between host response, antibiotic resistance, and virulence may modulate the severity of P. aeruginosa pneumonia in infected children.
Keywords: Antibiotic resistance; Childhood pneumonia; Host response; Pseudomonas aeruginosa; Risk assessment; Virulence factor.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.Chest. 2016 Aug;150(2):415-25. doi: 10.1016/j.chest.2016.03.042. Epub 2016 Apr 7. Chest. 2016. PMID: 27060725
-
Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.Crit Care Med. 2011 Sep;39(9):2113-20. doi: 10.1097/CCM.0b013e31821e899f. Crit Care Med. 2011. PMID: 21572326
-
Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice.BMC Genet. 2015 Aug 28;16:106. doi: 10.1186/s12863-015-0260-6. BMC Genet. 2015. PMID: 26310945 Free PMC article.
-
Pseudomonas aeruginosa: acute lung injury or ventilator-associated pneumonia?Minerva Anestesiol. 2010 Oct;76(10):824-32. Minerva Anestesiol. 2010. PMID: 20935618 Review.
-
Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.J Infect Dis. 2017 Feb 15;215(suppl_1):S44-S51. doi: 10.1093/infdis/jiw299. J Infect Dis. 2017. PMID: 28375513 Review.
Cited by
-
Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa.Int J Nanomedicine. 2019 Feb 25;14:1469-1487. doi: 10.2147/IJN.S191340. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30880959 Free PMC article.
-
Immune Efficacy of different immunization doses of divalent combination DNA vaccine pOPRL+pOPRF of Pseudomonas aeruginosa.J Vet Med Sci. 2021 Dec 23;83(12):1959-1964. doi: 10.1292/jvms.21-0036. Epub 2021 Nov 11. J Vet Med Sci. 2021. PMID: 34759080 Free PMC article.
-
Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains.Braz J Microbiol. 2021 Mar;52(1):267-278. doi: 10.1007/s42770-020-00406-x. Epub 2020 Nov 24. Braz J Microbiol. 2021. PMID: 33231865 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials